
Duncan Hall
Advertisement
Articles by Duncan Hall


Five months have flashed past since the CBI's risk-based monitoring event, and so I was looking forward to observing how much the industry has moved on.

Validation - a word we use a lot in this industry. For Triumph Consultancy Services, it is usually a term which we associate with systems development, but on this occasion I'm excited to say I'm talking about validation of our new business division and its ideas.
Advertisement
Latest Updated Articles
RBM Approaches Taking ShapePublished: April 3rd 2014 | Updated:
Triumph's Recap of CBI's Risk-Based Monitoring 2013Published: October 28th 2013 | Updated:
RBM Toolkit: Top 10 Core Key Risk IndicatorsPublished: November 11th 2015 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Outlines New Superiority Standard for Future CAR-T Approvals
2
Drug Repurposing Through AI-Driven In-Silico Clinical Trials
3
2025 Veeva R&D and Quality Summit: Advancing Site Efficiency and Collaboration in the Next Era of Clinical Trials
4
ACT Brief: Governance-Driven eCOA Acceleration, Site Operations Innovation, and New Momentum for Earlier CAR-T
5

.png)



.png)



.png)
.png)
